Pharmaceutical developers are increasingly asked by regulators to include imaging analysis when evaluating clinical trial data. In this video, ERT’s Vice President of Imaging addresses questions related to this trend:
- What’s driving the growing need for imaging in clinical development?
- What challenges to sponsors face when incorporating imaging into clinical trials?
- What over read challenges exist with traditional imaging processes?